Tandem Diabetes Care (TNDM) Net Income towards Common Stockholders Growth (5y) (2018 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Net Income towards Common Stockholders Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.26 Bn | 808.29 Mn | 144.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -48.83% |
| Mar 31, 2026 | -32.06% |
| Dec 31, 2025 | -15.23% |
| Sep 30, 2025 | -17.50% |
| Jun 30, 2025 | -14.10% |
| Mar 31, 2025 | -54.37% |
| Dec 31, 2024 | -21.81% |
| Sep 30, 2024 | -51.63% |
| Jun 30, 2024 | -82.78% |
| Mar 31, 2024 | -13.20% |
| Dec 31, 2023 | -58.89% |
| Sep 30, 2023 | 0.76% |
| Jun 30, 2023 | -21.17% |
| Mar 31, 2023 | -51.76% |
| Dec 31, 2022 | -10.73% |
| Sep 30, 2022 | -30.16% |
| Jun 30, 2022 | 4.39% |
| Mar 31, 2022 | 7.01% |
| Dec 31, 2021 | 22.94% |
| Sep 30, 2021 | 17.11% |